Piper Sandler on Kestra Medical Technologies (KMTS): 'Buy The Dip on Leverage Concerns'

September 15, 2026 11:01 AM

Piper Sandler analyst Matt O\'Brien reiterated an Overweight rating and $30.00 price target on Kestra Medical Technologies (NASDAQ: KMTS).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found